Mexico kicked off 2017 with a 20 percent spike in gasoline prices, driven in part by the phasing out of subsidies. Some consumers set fires at gas stations—a response that highlights the backlash countries can face as they stop subsidizing carbon-based fuels and start encouraging climate-friendly alternatives. Now the Mexican government and stock market are experimenting with a gentler tool for discouraging carbon emissions: cap-and-trade. Mexico, which in 2012 passed the developing world’s first climate law, is well placed to set an example for other developing economies looking to shrink their carbon footprints.
Continue reading Emission Permission
When the rains failed to come last year in central Isiolo County, Kenya, Mohamed Dahir figured he might lose 40% of his herd of 400 sheep and goats. Like several million other pastoralists in northern Kenya and across the border in Somalia and Ethiopia, Dahir and his herd live migrating between pastures.
Dahir did indeed lose some animals, but he received a payout from an emerging kind of livestock insurance: based on predictions of vegetation growth in the area and how many animals that might harm, his index-based livestock insurance policy gave him 50,000 Kenyan shillings (about £370) in cash before the drought and its consequences really settled in. He was able to buy enough hay from distant counties to save 95% of his herd. Continue reading How Kenya’s herders got their livestock insured
There’s open-source software, open-source pharma research, and open-source beer. Now, there are open-source seeds, too. Breeders from Göttingen University in Germany and Dottenfelderhof agricultural school in Bad Vilbel, Germany, have released tomato and wheat varieties under an open-source license. Their move follows similar schemes for sharing plant material in India and the United States, but is the first that provides legal protection for the open-source status of future descendants of plant varieties. Continue reading German breeders develop ‘open source’ plant seeds
When pharmacologist Ravindra Ghooi learned in 1996 that his mother had terminal breast cancer, he began to investigate whether he could obtain morphine, in case she needed pain relief at the end of her life. But a morphine prescription in India at that time, even for the dying, was a rare thing: most states required four or five different licences to buy painkillers such as morphine, and there were harsh penalties for minor administrative errors. Few pharmacies stocked opioids and it was a rare doctor who held the necessary paperwork to prescribe them. Ghooi, who is now a consultant at Cipla Palliative Care and Training Centre in Pune, used his connections to ask government and industry officials if there was a straightforward way of obtaining morphine for his mother. “Everybody agreed to give me morphine,” he recalls, “but they said they’d give it to me illegally.” Continue reading Palliative care: The other opioid issue